| abstract |
New pharmaceutical compositions in unit dosage form are disclosed for both intraoral and oral administration to a patient, said unit dosage form configured to be placed intraorally of said patient. The dosage form is as described in Figure 1, which comprises: (a) as a first portion, at least one discrete molded triturate tablet comprising a therapeutically effective amou nt of at least one pharmaceutically active ingredient capable of intraoral administration ; and (b) as a second portion located around the said first portion, a therapeutically effective amount of at least one p harmaceuticall y active ingredient capable of oral administration and which is releasable and orally ingestible by the patient after the molded triturate tablet has disintegrated or has dissolved intraorally. |